The monoclonal antibody therapies made by Regeneron and Eli Lilly, which the omicron coronavirus variant has essentially rendered useless, are still in high use in 12 states, Kaiser Health News reported Jan. 21.
The CDC’s National Institute for Occupational Safety and Health faces a backlog of applications from manufacturers seeking regulatory approval for N95s and other air-filtering masks, Roll Call reported Jan. 19.
Experts say many industries could face further supply chain disruptions if China imposes widespread lockdown measures to curb the spread of the omicron variant, The New York Times reported Jan. 16.
The Biden administration’s plan to distribute 1 billion rapid COVID-19 tests is putting pressure on manufacturers and distributors to bolster tight nationwide supplies, The Wall Street Journal reported Jan. 16.
The Los Angeles County Department of Health Services said blood shortages forced the trauma center at Harbor-UCLA Medical Center to close for several hours on Jan. 10, The Los Angeles Times reported.